ACADIA Pharmaceuticals (ACAD) had the highest return between November 15, 2012 and January 1, 2016 by a mid-cap US stock, returning 1,737.6%.
| ASSET | DATE | % RETURN |
|---|---|---|
ACADIA Pharmaceuticals (ACAD) | 11/15/2012 - 1/1/2016 | 1,737.63% |
Vipshop (VIPS) | 11/15/2012 - 1/1/2016 | 1,144.48% |
Travere Therapeutics (TVTX) | 11/15/2012 - 1/1/2016 | 859.7% |
Celsius (CELH) | 11/15/2012 - 1/1/2016 | 645.91% |
Ambarella (AMBA) | 11/15/2012 - 1/1/2016 | 633.42% |
BioCryst Pharmaceuticals (BCRX) | 11/15/2012 - 1/1/2016 | 626.76% |
Applied Digital (APLD) | 11/15/2012 - 1/1/2016 | 580% |
Pampa Energia SA ADR (PAM) | 11/15/2012 - 1/1/2016 | 524.62% |
Ligand Pharmaceuticals (LGND) | 11/15/2012 - 1/1/2016 | 514.97% |
JOYY (JOYY) | 11/15/2012 - 1/1/2016 | 494.95% |
Grupo Financiero Galicia SA ADR (GGAL) | 11/15/2012 - 1/1/2016 | 477.96% |
MGIC Investment (MTG) | 11/15/2012 - 1/1/2016 | 466% |
Nexstar Broadcasting (NXST) | 11/15/2012 - 1/1/2016 | 454.5% |
TG Therapeutics (TGTX) | 11/15/2012 - 1/1/2016 | 452.31% |
TAL Education (TAL) | 11/15/2012 - 1/1/2016 | 446.64% |
Catalyst Pharmaceuticals (CPRX) | 11/15/2012 - 1/1/2016 | 445.9% |
Transportadora de Gas del Sur SA ADR (TGS) | 11/15/2012 - 1/1/2016 | 437.23% |
Repligen (RGEN) | 11/15/2012 - 1/1/2016 | 434.78% |
BBVA Banco Frances SA ADR (BBAR) | 11/15/2012 - 1/1/2016 | 426.48% |
Manhattan Associates (MANH) | 11/15/2012 - 1/1/2016 | 374.59% |
Himax Technologies (HIMX) | 11/15/2012 - 1/1/2016 | 354.96% |
Banco Macro SA B ADR (BMA) | 11/15/2012 - 1/1/2016 | 331.94% |
Pilgrims Pride (PPC) | 11/15/2012 - 1/1/2016 | 322.07% |
MarketAxess (MKTX) | 11/15/2012 - 1/1/2016 | 314.58% |
Boyd Gaming (BYD) | 11/15/2012 - 1/1/2016 | 312.24% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.